How to avoid rediscovering the known

Methods in Enzymology

Volumn 493, Issue , 2011, Pages 159-168

  Kuo, Lawrence C ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ISOQUINOLINE; PROTEIN BCL XL; QUINAZOLINE;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CAPILLARY ELECTROPHORESIS; CRYSTAL STRUCTURE; DRUG RESEARCH; FRAGMENT BASED DRUG DISCOVERY; HIGH THROUGHPUT SCREENING; ISOTHERMAL TITRATION CALORIMETRY; MASS SPECTROMETRY; METHODOLOGY; MOLECULAR INTERACTION; MOLECULAR LIBRARY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PHARMACOPHORE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEIN TARGETING; SCREENING TEST; SURFACE PLASMON RESONANCE; X RAY CRYSTALLOGRAPHY;

EID: 79952378948     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381274-2.00007-8     Document Type: Chapter

References (23)

1. M.C. Abad, X. Zhang, and A.C. Gibbs Structure density relationship based FBDD Methods Enzymol. 2011 493, 489510
2. K. Babaoglu, and B.K. Shoichet Deconstructing fragment-based inhibitor discovery Nat. Chem. Biol. 2 2006 720 723 (Pubitemid 44764214)
3. L inhibitors J. Med. Chem. 2010 56, 25772588
4. J. Barker, S. Courtney, T. Hesterkamp, D. Ullmann, and M. Whittaker Fragment screening by biochemical assay Expert Opin. Drug Discov. 1 2006 225 236
5. N. Baurin, F. Aboul-Ela, X. Barril, B. Davis, M. Drysdale, B. Dymock, H. Finch, C. Fromont, C. Richardson, H. Simmonite, and R.E. Hubbard Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets J. Chem. Inf. Comput. Sci. 44 2004 2157 2166
6. M. Congreve, R. Carr, C. Murray, and H. Jhoti A "Rule of Three" for fragment-based lead discovery? Drug Discov. Today 8 2003 876 877 (Pubitemid 37194496)
7. R.L. DesJarlais Using computational techniques in fragment-based drug discovery Methods Enzymol. 2011 493, 137156
8. T. Fink, and J.-L. Reymond Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: Assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery J. Chem. Inf. Model. 47 2007 342 353 (Pubitemid 46615939)
9. P.J. Hajduk Fragment-based drug design: How big is too big? J. Med. Chem. 49 2006 6972 6976 (Pubitemid 44885985)
10. M.M. Hann, A.R. Leach, and G. Harper Molecular complexity and its impact on the probability of finding leads for drug discovery J. Chem. Inf. Comput. Sci. 41 2001 856 864
11. M.M. Hann, A.R. Leach, J.N. Burrows, and E. Griffen Lead discovery and the concepts of complexity and lead-likeness in the evolution of drug candidates Compr. Med. Chem. II 4 2006 435 458
12. T. Hesterkamp, and M. Whittaker Fragment-based activity space: Smaller is better Curr. Opin. Chem. Biol. 12 2008 260 268
13. R.E. Hubbard, B. Davis, I. Chen, and M.J. Drysdale The SeeDs approach: Integrating fragments into drug discovery Curr. Top. Med. Chem. 7 2007 1568 1581 (Pubitemid 350131015)
14. I.D. Kuntz, K. Chen, K.A. Sharp, and P.A. Kollman The maximal affinity of ligands Proc. Natl. Acad. Sci. USA 96 1999 9997 10002 (Pubitemid 29422500)
15. R. Law, O. Barker, J.J. Barker, T. Hesterkamp, R. Godemann, O. Andersen, T. Fryatt, S. Courtney, D. Hallett, and M. Whittaker The multiple roles of computational chemistry in fragment-based drug design J. Comput. Aided Mol. Des. 23 2009 459 473
16. C.A. Lepre Library design for NMR-based screening Drug Discov. Today 6 2001 133 140 (Pubitemid 32098287)
17. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3 26 (Pubitemid 33653411)
18. T.I. Oprea, A.M. Davis, S.J. Teague, and P.D. Leeson Is there a difference between leads and drugs? A historical perspective J. Chem. Inf. Comput. Sci. 41 2001 1308 1315
19. M. Orita, M. Warizaya, Y. Amano, K. Ohno, and T. Niimi Advances in fragment-based drug discovery platforms Expert Opin. Drug Discov. 4 2009 1125 1144
20. D.E. Patterson, R.D. Cramer, A.M. Ferguson, R.D. Clark, and L.E. Weinberger Neighborhood behavior: A useful concept for validation of "molecular diversity" descriptors J. Med. Chem. 39 1996 3049 3059 (Pubitemid 26260310)
21. S.-A. Poulsen, and G.H. Kruppa In situ fragment-based medicinal chemistry: Screening by mass spectrometry E.R. Zartler, M.J. Shapiro, Fragment-Based Drug Discovery: A Practical Approach 2008 John Wiley & Sons, Ltd. UK 159 198
22. W. Sun, G. Struble, and L.C. Kuo 2010 Unpublished observations
23. S.J. Teague, A.M. Davis, P.D. Leeson, and T. Oprea The design of leadlike combinatorial libraries Angew. Chem. Int. Ed. 38 1999 3743 3747